diabetic ckd (finerenone) MCQ (SBA): Nephrology

Instant feedback + full explanation. One question, done properly.

HardADA Standards of Care (2025): CKD and Risk Management; KDIGO (2024): CKDNephrologydiabetic ckd (finerenone)

A 68-year-old with CKD and proteinuria has BP controlled and is on ACEi and SGLT2 inhibitor. Persistent UACR 900 mg/g. What additional renoprotective option is emerging per guidance?

Educational content. Not a substitute for clinical judgement or local policy.

diabetic ckd (finerenone) MCQ: Nephrology — Answer & Explanation | iat